Journal of Neural Transmission

, Volume 112, Issue 9, pp 1237–1248

Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian

  • C. Barcia
  • V. Bautista
  • Á. Sánchez-Bahillo
  • E. Fernández-Villalba
  • B. Faucheux
  • M. Poza y Poza
  • A. Fernandez Barreiro
  • E. C. Hirsch
  • M.-T. Herrero


The degeneration of nigral dopaminergic neurons in Parkinson’s disease is believed to be associated with a glial reaction and inflammatory changes. In turn, local factors may induce changes in vascularization and contribute to neuronal vulnerability. Among these factors, Vascular Endothelial Growth Factor (VEGF) is released in adults under pathological conditions and is thought to induce angiogenesis.

In order to determine whether changes in brain vasculature are observed in the affected brain regions in parkinsonism, we quantitatively analysed the VEGF-expressing cells and blood vessels in the substantia nigra of monkeys rendered parkinsonian by MPTP injection and compared the results with those obtained in control monkeys.

Using stereological methods, we observed an increase in the number of VEGF-expressing neurons and an increase of the number of blood vessels and their volume occupying the substantia nigra pars compacta of monkeys rendered parkinsonian by chronic MPTP intoxication. These changes in vascularization may therefore modify the neuronal availability of blood nutrients, blood cells or toxic substances and neuronal susceptibility to parkinsonism.

Keywords: Parkinson’s disease, MPTP, brain inflammation. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barcia, C, Bautista, V, Sanchez-Bahillo, A, Fernandez-Villalba, E, Navarro-Ruis, JM, Barreiro, AF, Poza, Y, Poza, M, Herrero, MT 2003Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys.Neuroendocrinology78118128CrossRefPubMedGoogle Scholar
  2. Barcia, C, De Pablos, V, Bautista-Hernandez, V, Sanchez-Bahillo, A, Fernandez-Barreiro, A, Poza, M, Herrero, MT 2004aMeasurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity.J Neurosci Methods1345964CrossRefGoogle Scholar
  3. Barcia, C, Sanchez Bahillo, A, Fernandez-Villalba, E, Bautista, V, Poza y Poza, M, Fernandez-Barreiro, A, Hirsch, EC, Herrero, MT 2004bEvidence of active microglia insubstantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.Glia46402409CrossRefGoogle Scholar
  4. Beck, H, Acker, T, Puschel, AW, Fujisawa, H, Carmeliet, P, Plate, KH 2002Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling.J Neuropathol Exp Neurol61339350PubMedGoogle Scholar
  5. Breier, G, Albrecht, U, Sterrer, S, Risau, W 1992Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.Development114521532PubMedGoogle Scholar
  6. Brightman, MW 1965The distribution within the brain of ferritin injected into cerebrospinal fluid compartments. II. Parenchymal distribution.Am J Anat117193219CrossRefPubMedGoogle Scholar
  7. Carmerliet, P, Rakesh, KJ 2000Angiogenesis in cancer and other diseases.Nature407249257CrossRefPubMedGoogle Scholar
  8. Casper, D, Engstrom, SJ, Mirchandani, GR, Pidel, A, Palencia, D, Cho, PH, Brownlee, M, Edelstein, D, Federoff, HJ, Sonstein, WJ 2002Enhanced vascularization and survival of neural transplants with ex vivo angiogenic gene transfer.Cell Transplant11331349PubMedGoogle Scholar
  9. Chavez, JC, Agani, F, Pichiule, P, LaManna, JC 2000Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia.J Appl Physiol8919371942PubMedGoogle Scholar
  10. Emanueli, C, Schratzberger, P, Kirchmair, R, Madeddu, P 2003Paracrine control of vascularization and neurogenesis by neurotrophins.Br J Pharmacol140614619CrossRefPubMedGoogle Scholar
  11. Famiglietti, EV, Stopa, EG, McGookin, ED, Song, P, LeBlanc, V, Streeten, BW 2003Immunocytochemical localization of vascular endothelial growth factor in neurons and glial cells of human retina.Brain Res969195204CrossRefPubMedGoogle Scholar
  12. Faucheux, BA, Nillesse, N, Damier, P, Spik, G, Mouatt-Prigent, A, Pierce, A, Leveugle, B, Kubis, N, Hauw, JJ, Agid, Y, Hirsch, EC 1995Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.Proc Natl Acad Sci USA9296039607PubMedGoogle Scholar
  13. Faucheux, BA, Bonnet, AM, Agid, Y, Hirsch, EC 1999Blood vessels change in the mesencephalon of patients with Parkinson’s disease.Lancet353981982CrossRefGoogle Scholar
  14. Fearnley, JM, Lees, AJ 1991Ageing and Parkinson’s disease: substantia nigra regional selectivity.Brain11422832301PubMedGoogle Scholar
  15. Felten, DL, Crutcher, KA 1979Neuronal-vascular relationships in the raphe nuclei, locus coeruleus, and substantia nigra in primates.Am J Anat155467481CrossRefPubMedGoogle Scholar
  16. Graybiel, AM, Ragsdale, CW,Jr 1978Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining.Proc Natl Acad Sci USA7557235726PubMedGoogle Scholar
  17. Han, MK, Kim, M, Bae, SY, Kang, L, Han, SY, Lee, YS, Rha, JH, Kim, SU, Roh, JK 2004VEGF protects human cerebral hybrid neurons from in vitro ischemia.Neuroreport15847850CrossRefPubMedGoogle Scholar
  18. Hartmann, A, Hunot, S, Michel, PP, Muriel, MP, Vyas, S, Faucheux, BA, Mouatt-Prigent, A, Turmel, H, Srinivasan, A, Ruberg, M, Evan, GI, Agid, Y, Hirsch, EC 2000Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease.Proc Natl Acad Sci USA9728752880CrossRefPubMedGoogle Scholar
  19. Hayashi, T, Abe, K, Suzuki, H, Itoyama, Y 1997Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats.Stroke2820392044PubMedGoogle Scholar
  20. Herrero, MT, Hirsch, EC, Kastner, A, Ruberg, M, Luquin, MR, Laguna, J, Javoy-Agid, F, Obeso, JA, Agid, Y 1993aDoes neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?Neuroscience56499511CrossRefGoogle Scholar
  21. Herrero, MT, Hirsch, EC, Kastner, A, Luquin, MR, Javoy-Agid, F, Gonzalo, LM, Obeso, JA, Agid, Y 1993bNeuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.Dev Neurosci153748Google Scholar
  22. Herrero, MT, Perez-Otaño, I, Oset, C, Kastner, A, Hirsch, EC, Agid, Y, Luquin, MR, Obeso, JA, Del Rio, J 1993cGM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.Neuroscience56965972CrossRefGoogle Scholar
  23. Hirsch, EC 1992Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson’s disease?Ann Neurol32S88S93CrossRefPubMedGoogle Scholar
  24. Hirsch, EC, Faucheux, BA 1998Iron metabolism and Parkinson’s disease.Mov Disord133945CrossRefGoogle Scholar
  25. Hirsch, E, Graybiel, AM, Agid, YA 1988Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson’s disease.Nature334345348CrossRefPubMedGoogle Scholar
  26. Hunot, S, Brugg, B, Ricard, D, Michel, PP, Muriel, MP, Ruberg, M, Faucheux, BA, Agid, Y, Hirsch, EC 1997Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.Proc Natl Acad Sci USA9475317536CrossRefPubMedGoogle Scholar
  27. Imbert, C, Bezard, E, Guitraud, S, Boraud, T, Gross, CE 2000Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey.J Neurosci Methods967176CrossRefPubMedGoogle Scholar
  28. Jin, KL, Mao, XO, Greenberg, DA 2000aVascular endothelial growth factor: direct neuroprotective effect in vitro ischemia.Proc Natl Acad Sci USA971024210247CrossRefGoogle Scholar
  29. Jin, KL, Mao, XO, Greenberg, DA 2000bVascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal.J Mol Neurosci14197203CrossRefGoogle Scholar
  30. Jin, K, Mao, XO, Batteur, SP, McEachron, E, Leahy, A, Greenberg, DA 2001Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor.Neuroscience108351358CrossRefPubMedGoogle Scholar
  31. Josko, J 2003Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats.Brain Res9815869CrossRefPubMedGoogle Scholar
  32. Lee, MY, Ju, WK, Cha, JH, Son, BC, Chun, MH, Kang, JK, Park, CK 1999Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats.Neurosci Lett265107110CrossRefPubMedGoogle Scholar
  33. Lennmyr, F, Ata, KA, Funa, K, Olsson, Y, Terent, A 1998Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat.J Neuropathol Exp Neurol57874882PubMedGoogle Scholar
  34. Luquin, MR, Laguna, J, Herrero, MT, Obeso, JA 1993Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys.J Neurol Sci1144044CrossRefPubMedGoogle Scholar
  35. Matsuzaki, H, Tamatani, M, Yamaguchi, A, Namikawa, K, Kiyama, H, Vitek, MP, Mitsuda, N, Tohyama, M 2001Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades.FASEB J1512181220PubMedGoogle Scholar
  36. McGeer, EG, McGeer, PL 1997The role of the immune system in neurodegenerative disorders.Mov Disord12855858CrossRefPubMedGoogle Scholar
  37. Naoumenko, J, Feigin, I 1974A simple silver solution for staining reticulin.Stain Technol49153155PubMedGoogle Scholar
  38. Nico, B, Corsi, P, Vacca, A, Roncali, L, Ribatti, D 2002Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain.Brain Res9531216CrossRefPubMedGoogle Scholar
  39. Ogunshola, OO, Antic, A, Donoghue, MJ, Fan, SY, Kim, H, Stewart, WB, Madri, JA, Ment, LR 2002Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system.J Biol Chem2771141011415CrossRefPubMedGoogle Scholar
  40. Olzewski J, Baxter D (1954) Cytoarchitecture of the human brain stem. JB Lippincott, PhiladelphiaGoogle Scholar
  41. Pinedo, HM, Verheul, HM, D’Amato, RJ, Folkman, J 1998Involvement of platelets in tumour angiogenesis?Lancet35217751777CrossRefPubMedGoogle Scholar
  42. Reese, TS, Karnovsky, MJ 1967Fine structural localization of a blood-brain barrier to exogenous peroxidase.J Cell Biol34207217CrossRefPubMedGoogle Scholar
  43. Risau, W 1997Mechanisms of angiogenesis.Nature386671674CrossRefPubMedGoogle Scholar
  44. Seljelid, R, Jozefowski, S, Sveinbjornsson, B 1999Tumor stroma.Anticancer Res1948094822PubMedGoogle Scholar
  45. Silverman, WF, Krum, JM, Mani, N, Rosenstein, JM 1999Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures.Neuroscience9015291541CrossRefPubMedGoogle Scholar
  46. Sondell, M, Kanje, M 2001Postnatal expression of VEGF and its receptor flk-1 in peripheral ganglia.Neuroreport12105108CrossRefPubMedGoogle Scholar
  47. Sondell, M, Sundler, F, Kanje, M 2000Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor.Eur J Neurosci1242434254CrossRefPubMedGoogle Scholar
  48. Sterio, DC 1984The unbiased estimation of number and sizes of arbitrary particles using the disector.J Microsc134127136PubMedGoogle Scholar
  49. Stone, J, Itin, A, Alon, T, Pe’er, J, Gnessin, H, Chan-Ling, T, Keshet, E 1995Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia.J Neurosci1547384747PubMedGoogle Scholar
  50. Tischer, E, Mitchell, R, Hartman, T, Silva, M, Gospodarowicz, D, Fiddes, JC, Abraham, JA 1991The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.J Biol Chem2661194711954PubMedGoogle Scholar
  51. Yancopoulos, GD, Davis, D, Gale, NW, Rudge, JS, Wiegand, SJ, Holash, J 2000Vascular-specific growth factors and blood vessels formation.Nature407242248CrossRefPubMedGoogle Scholar
  52. Yasuhara, T, Shingo, T, Kobayashi, K, Takeuchi, A, Yano, A, Muraoka, K, Matsui, T, Miyoshi, Y, Hamada, H, Date, I 2004Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson’s disease.Eur J Neurosci1914941504CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • C. Barcia
    • 1
  • V. Bautista
    • 1
  • Á. Sánchez-Bahillo
    • 1
  • E. Fernández-Villalba
    • 1
  • B. Faucheux
    • 2
  • M. Poza y Poza
    • 1
  • A. Fernandez Barreiro
    • 1
  • E. C. Hirsch
    • 2
  • M.-T. Herrero
    • 1
  1. 1.Experimental Neurology and Neurosurgery Group, Department of Human Anatomy and Psychobiology, Medical SchoolUniversity of MurciaMurciaSpain
  2. 2.INSERM U289, Hôpital de la SalpêtrièreParisFrance

Personalised recommendations